FMTVDM Measurements & Their Meaning
FMTVDM measurements vary depending upon what part of the body - tissue - is being looked at, what health problem we are looking for (Heart Disease, Cancer, Co-Vid-19, et cetera), what type of camera is being used, what isotope, what enhancing agent and what timing sequence.
​
E.g. the FMTVDM measurements obtained by planar, SPECT and PET cameras are different. If you are going to compare outcomes you cannot compare apples with oranges. While they are both fruit, they are not the same fruit.​
To avoid confusion, protect Intellectual Property, and not put you through a decade of medical training, the following data will look at the results of Breast Cancer imaging done with a SPECT camera using one specific protocol written for FMTVDM.
​
​
The following graph shows the results of the first 100-200 women and men who were studied using this particular approach. These results were compared with matching biopsy data.
The results shown in the following graph compared the region of greatest - maximum count activity (MCA) - measured regional blood flow and metabolic activity with the biopsy results. It does not show the variance in that activity, which as discussed in the last page of this website, is important information for understanding tissue behavior.
As you can see, there is an increase in regional metabolic and blood flow as the tissue undergoes InflammoThrombotic Immunologic Response (ITIR) changes, transitioning from healthy breast tissue, which we consider normal and abnormal unhealthy tissue.
Clearly a woman, or man, does not go from having healthy tissue to breast cancer. The tissue changes following increased in regional blood flow and metabolism. Changes that can result from a variety of factors. [https://www.flemingmethod.com/]
By convention, using a you have cancer or you don't approach is simply wrong! While you may be at one extreme or the other of your health spectrum, you didn't transition overnight. Thinking about the health of people or using billing codes based on such an approach is not practicing medicine. It's practicing ignorance.
​​
What should also be apparent is the rather dramatic increase in regional metabolism and blood flow that occurs once the tissue has transitioned through several earlier ITIRD stages; finally reaching the last ITIRD stage, i.e. cancer.
It was at this point in my investigations that I stepped back and realized that the process of simply distinguishing between normal, inflammation (ITIR) and cancer, was itself over simplified. If these changes in tissue are truly transitional, then FMTVDM should be able to appreciate changes within these groups.
​
With additional research, it became apparent, that there are measurable differences between the ITIRD Diseases (ITRDs) we call inflammation, the ITIRD state we call cellular atypia, and the ITIRD state we call cancer.
​
The results of some of that research is shown in the following bar graph, distinguishing measured differences between the ITIRD states of normal healthy tissue, inflammatory, cellular atypia and cancer.
Thinking in such simplistic terms - you either have cancer or you don't - ignores the reality of what truly happens as tissue transitions across the spectrum of ITIRDs. You simply don't go from having completely normal healthy tissue to having cancer.
​
The evidence shows tissue goes through transitional ITIRD stages. The earlier this transitional change is found, the greater the likelihood it can be reversed and health restored. Potentially using less toxic treatments, including what some might argue are more natural treatment methods.
​
In fact, a series of presentations I gave during 2023 to 2024 [https://www.flemingmethod.com/answers], demonstrated how combining conventional cancer treatments with other treatments (vitamins and other compounds) could result in better outcomes - particularly in individuals whose cancers were refractory (no longer responded) to the treatments they had been receiving; clutching success out of the mouth of defeat.
​​
As I continued my FMTVDM investigations, I discovered this ITIRD transitional process could be broken down still further. My findings supported a hypothesis proposed many years before by Gompertz and Laird who independently thought cancers might not undergo continuous change over time. I.e. there would be periods of growth followed by periods of less growth.
Based upon the measured FMTVDM results, the ITIRD transitional process appears to be curvilinear in character as shown in the following graph. This indicates that as ITIRD tissue transitions, the change in regional metabolism and blood flow appears slowly at first, then linearly and finally, once sufficient changes in regional blood flow and metabolism occur, the change becomes more aggressive.
​
There is even evidence that this ITIRD process begins to slow down as the cancer outstrips its blood supply, resulting in cancer cell death, which results in calcium being leached out of the dead cancer cells where it can finally be seen with anatomic imaging tests including mammography, x-rays, et cetera.
The ability to make such FMTVDM measurements not only reinforces the work of Gompertz and Laird, it solidifies the concept of medical thinking must be in terms of a Health-Spectrum, and not a yes/no, CPT/ICD billing approach.
One of the first and best indications that someone is finally beginning to understand FMTVDM measurement and tissue differentiation, is their ability to recognize that FMTVDM can be used to measure whether their treatment is working or not - i.e. whether the person is becoming healthier.